WO1998051704A1 - PEPTIDES PROMOTING THE ACTIVATION OF LATENT TGF-β AND METHOD FOR SCREENING TGF-β ACTIVITY REGULATORS - Google Patents
PEPTIDES PROMOTING THE ACTIVATION OF LATENT TGF-β AND METHOD FOR SCREENING TGF-β ACTIVITY REGULATORS Download PDFInfo
- Publication number
- WO1998051704A1 WO1998051704A1 PCT/JP1998/002089 JP9802089W WO9851704A1 WO 1998051704 A1 WO1998051704 A1 WO 1998051704A1 JP 9802089 W JP9802089 W JP 9802089W WO 9851704 A1 WO9851704 A1 WO 9851704A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- tgf
- promoting
- activity
- screening
- latent
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/495—Transforming growth factor [TGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/475—Assays involving growth factors
- G01N2333/495—Transforming growth factor [TGF]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Endocrinology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP54904498A JP4104671B2 (ja) | 1997-05-12 | 1998-05-12 | 潜在型TGF―βの活性化を促進するペプチドおよびTGF―β活性調節化合物のスクリーニング方法 |
EP19980919563 EP0922710A4 (en) | 1997-05-12 | 1998-05-12 | PEPTIDES SUPPORTING THE ACTIVATION OF LATENT TGF-BETA AND A METHOD FOR IDENTIFYING REGULATORS OF TGF-BETA ACTIVITY. |
CA002259956A CA2259956A1 (en) | 1997-05-12 | 1998-05-12 | Peptides promoting the activation of latent tgf-.beta. and method for screening tgf-.beta. activity regulators |
AU72360/98A AU736207B2 (en) | 1997-05-12 | 1998-05-12 | Peptides which promote activation of latent TGF-beta and method of screening TGF-beta activity-regulating compounds |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP12068397 | 1997-05-12 | ||
JP9/120683 | 1997-05-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1998051704A1 true WO1998051704A1 (en) | 1998-11-19 |
Family
ID=14792374
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP1998/002089 WO1998051704A1 (en) | 1997-05-12 | 1998-05-12 | PEPTIDES PROMOTING THE ACTIVATION OF LATENT TGF-β AND METHOD FOR SCREENING TGF-β ACTIVITY REGULATORS |
Country Status (8)
Country | Link |
---|---|
US (1) | US20030027218A1 (ja) |
EP (1) | EP0922710A4 (ja) |
JP (1) | JP4104671B2 (ja) |
KR (1) | KR20000023669A (ja) |
CN (1) | CN1226898A (ja) |
AU (1) | AU736207B2 (ja) |
CA (1) | CA2259956A1 (ja) |
WO (1) | WO1998051704A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005105144A1 (ja) * | 2004-04-30 | 2005-11-10 | Kyowa Hakko Kogyo Co., Ltd. | 潜在型TGF-βの活性化抑制剤 |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6756215B1 (en) * | 2000-10-20 | 2004-06-29 | The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services | Functionalized TGF-β fusion proteins |
JP6975896B2 (ja) | 2017-02-03 | 2021-12-01 | パナソニックIpマネジメント株式会社 | 撮像装置の制御方法及び撮像装置 |
KR102069184B1 (ko) * | 2019-06-28 | 2020-01-22 | (주)미래씨티 | 신경줄기세포 추출물유래 bmp신호전달경로 억제 펩타이드 및 상기 펩타이드를 유효성분으로 포함하는 발모촉진 또는 탈모방지 조성물 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6014171A (ja) * | 1983-07-05 | 1985-01-24 | Toyo Jozo Co Ltd | トランスホ−ミンググロスファクタ−の定量方法 |
JPH08510443A (ja) * | 1993-01-26 | 1996-11-05 | セルトリックス ファーマシューティカルズ,インコーポレイテッド | 生物学的に活性なTGF−β1およびTGF−β2ペプチド |
-
1998
- 1998-05-12 EP EP19980919563 patent/EP0922710A4/en not_active Withdrawn
- 1998-05-12 WO PCT/JP1998/002089 patent/WO1998051704A1/ja not_active Application Discontinuation
- 1998-05-12 AU AU72360/98A patent/AU736207B2/en not_active Ceased
- 1998-05-12 US US09/214,592 patent/US20030027218A1/en not_active Abandoned
- 1998-05-12 CN CN98800622A patent/CN1226898A/zh active Pending
- 1998-05-12 JP JP54904498A patent/JP4104671B2/ja not_active Expired - Fee Related
- 1998-05-12 CA CA002259956A patent/CA2259956A1/en not_active Abandoned
-
1999
- 1999-01-09 KR KR1019997000124A patent/KR20000023669A/ko not_active Application Discontinuation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6014171A (ja) * | 1983-07-05 | 1985-01-24 | Toyo Jozo Co Ltd | トランスホ−ミンググロスファクタ−の定量方法 |
JPH08510443A (ja) * | 1993-01-26 | 1996-11-05 | セルトリックス ファーマシューティカルズ,インコーポレイテッド | 生物学的に活性なTGF−β1およびTGF−β2ペプチド |
Non-Patent Citations (2)
Title |
---|
SATO Y., ET AL.: "THE MECHANISM FOR THE ACTIVATION OF LATENT TGF-BETA DURING CO- CULTURE OF ENDOTHELIAL CELLS AND SMOOTH MUSCLE CELLS: CELL-TYPE SPECIFIC TARGETING OF LATENT TGF-BETA TO SMOOTH MUSCLE CELLS.", THE JOURNAL OF CELL BIOLOGY : JCB, THE ROCKEFELLER UNIVERSITY PRESS, US, vol. 123., no. 05., 1 December 1993 (1993-12-01), US, pages 1249 - 1254., XP002914417, ISSN: 0021-9525, DOI: 10.1083/jcb.123.5.1249 * |
See also references of EP0922710A4 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005105144A1 (ja) * | 2004-04-30 | 2005-11-10 | Kyowa Hakko Kogyo Co., Ltd. | 潜在型TGF-βの活性化抑制剤 |
Also Published As
Publication number | Publication date |
---|---|
US20030027218A1 (en) | 2003-02-06 |
EP0922710A1 (en) | 1999-06-16 |
KR20000023669A (ko) | 2000-04-25 |
AU7236098A (en) | 1998-12-08 |
JP4104671B2 (ja) | 2008-06-18 |
CA2259956A1 (en) | 1998-11-19 |
EP0922710A4 (en) | 2002-10-25 |
CN1226898A (zh) | 1999-08-25 |
AU736207B2 (en) | 2001-07-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002211317A1 (en) | Methods and compositions for directed microwave chemistry | |
WO1999039740A8 (en) | Sensitizing cells to compounds using lipid-mediated gene and compound delivery | |
EP0933365A3 (en) | Growth hormone secretagogues | |
EP1507005A3 (en) | Antisense modulation of BCL-X expression | |
AU2560599A (en) | Diagnosis and treatment of aur1 and/or aur2 related disorders | |
BR0114630A (pt) | Secretagogos de hormÈnio do crescimento | |
BR0309278A (pt) | Composto, composição, métodos para modular a atividade da cinesina ksp, para inibir a ksp, para o tratamento de uma doença proliferativa celular, e, uso de um composto | |
WO1998000532A3 (en) | Oligonucleotides from the untranslated regions of ribonucleotide reductase and their use to modulate cell growth | |
AU8863398A (en) | Coating composition comprising an oxazolidine functional compound and an isocyanate functional compound comprising uretdione and/or allophanate structure | |
AU8005598A (en) | New uses for compounds which reduce (c-jun) gene expression | |
ZA9810915B (en) | Optimization of cells for endogenous gene activation. | |
ZA988674B (en) | 21-Hydroy-6,19-oxidoprogesterone (21OH-6OP) for treating excess of glucocorticoids | |
GB9907813D0 (en) | Synthesis | |
MY138257A (en) | Compositions and methods for enhancing delivery of therapeutic agents to cells | |
ATE266030T1 (de) | 1,4,7,10-tetraazabicyclo(8.2.2)tetradecan-2-on, verfahren zu ihrer herstellung und ihrer verwendung für die herstellung von tetraazamacrocyclen | |
ATE236153T1 (de) | 4-trifluormethyl-3-oxazolylpyridine, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung als schädlingsbekämpfungsmittel | |
WO1998051704A1 (en) | PEPTIDES PROMOTING THE ACTIVATION OF LATENT TGF-β AND METHOD FOR SCREENING TGF-β ACTIVITY REGULATORS | |
EP1498104A4 (en) | TONIC PRODUCT FOR HAIR GROWTH | |
AU7969698A (en) | Munitions treatment by acid digestion | |
Shiosaki et al. | Development of CCK-tetrapeptide analogs as potent and selective CCK-A receptor agonists | |
AU6837298A (en) | Isocyanates modified for being provided with surfactant property, composition containing same, resulting coating | |
EP0292101A3 (en) | Process for the preparation of 3'-azido-3'-deoxythymidine and intermediates | |
WO2004003152A3 (en) | Sos1 inhibitors | |
AU2001252618A1 (en) | Cell proliferation inhibitors | |
WO1997039107A3 (en) | Methods for increasing the maturation of cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 98800622.7 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU BG BR CA CN CZ HU IL JP KR MX NO NZ PL RO SG SI SK UA US VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
ENP | Entry into the national phase |
Ref document number: 2259956 Country of ref document: CA Ref document number: 2259956 Country of ref document: CA Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09214592 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1019997000124 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 72360/98 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1998919563 Country of ref document: EP |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWP | Wipo information: published in national office |
Ref document number: 1998919563 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1019997000124 Country of ref document: KR |
|
WWG | Wipo information: grant in national office |
Ref document number: 72360/98 Country of ref document: AU |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1019997000124 Country of ref document: KR |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1998919563 Country of ref document: EP |